Westside Investment Management, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2024$05000.0%0.00%
Q1 2024$05000.0%0.00%
Q4 2023$05000.0%0.00%
Q3 2023$05000.0%0.00%
Q2 2023$05000.0%0.00%
Q1 2023$05000.0%0.00%
Q4 2022$05000.0%0.00%
Q3 2022$05000.0%0.00%
Q2 2022$05000.0%0.00%
Q1 2022$05000.0%0.00%
Q4 2021$05000.0%0.00%
Q3 2021$05000.0%0.00%
Q2 2021$05000.0%0.00%
Q1 2021$0
-100.0%
5000.0%0.00%
-100.0%
Q4 2020$1,235,000
-21.6%
5000.0%0.00%
+200.0%
Q3 2020$1,575,000
+8.2%
5000.0%0.00%0.0%
Q2 2020$1,455,000
-99.6%
500
-98.6%
0.00%
-99.6%
Q1 2020$405,912,000
+21263.8%
36,834
+7266.8%
0.28%
+6825.0%
Q2 2019$1,900,000
+20.3%
5000.0%0.00%
+300.0%
Q4 2018$1,580,000
+25.4%
5000.0%0.00%
Q3 2018$1,260,000
-1.6%
5000.0%0.00%
Q2 2018$1,280,000
+20.2%
5000.0%0.00%
-100.0%
Q1 2017$1,065,000
-8.2%
5000.0%0.00%0.0%
Q4 2016$1,160,0005000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,632,000$8,817,0002.83%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 551,804$1,848,543,0001.54%
Nine Chapters Capital Management LLC 24,300$81,0000.57%
GREAT POINT PARTNERS LLC 645,000$2,161,0000.55%
Virtus ETF Advisers LLC 198,901$666,0000.32%
GSA CAPITAL PARTNERS LLP 1,521,224$5,096,0000.27%
Amici Capital, LLC 200,000$670,0000.18%
Acrospire Investment Management LLC 70,622$237,0000.16%
RBF Capital, LLC 273,976$918,0000.16%
SECOR Capital Advisors, LP 383,971$1,286,0000.14%
View complete list of PDL BIOPHARMA INC shareholders